Advertisement
Advertisement
XLO
Xilio Therapeutics, Inc. Common Stock
8.62
USDSponsored
+0.12
+1.41%
Nov 06, 15:59 UTC -5
Closed
After-Market
8.79
+0.17
+1.91%
Xilio Therapeutics, Inc. Common Stock (XLO)
Xilio Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 57.81M |
| Beta | -0.13 |
| Earnings Per Share (EPS) | -1.64 |
| Price-to-Book (P/B) Ratio | 0.78 |
| Operating Margin | -48.30% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -71.99% |
| Current Ratio | 4.25% |
| Free Cash Flow | -41.68M |
